CRI

Carter's (CRI) emerges as the superior value stock compared to Nike (NKE) based on valuation metrics and analyst outlook. CRI has a Zacks Rank of #2 (Buy) with a forward P/E of 9.72, while NKE holds a Zacks Rank of #5 (Strong Sell) with a forward P/E of 26.64. CRI's Value grade of A significantly outperforms NKE's Value grade of D across multiple metrics including P/B ratio and PEG ratio.

Zacks identifies Carter's (CRI) as an attractive value investment opportunity, currently holding a Zacks Rank #2 (Buy) rating with an A grade for Value. The stock trades at a P/E ratio of 11.92 compared to its industry average of 19.32, and demonstrates favorable valuations across multiple metrics including P/B, P/S, and P/CF ratios, suggesting it is undervalued relative to its earnings outlook.